Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ariadne investigators"'
Autor:
Aldo P. Maggioni, Andrew L. Clark, Vivencio Barrios, Thibaud Damy, Jaroslaw Drozdz, Candida Fonseca, Lars H. Lund, Stefanie Kalus, Philippe C. Ferber, Rizwan I. Hussain, Cornelia Koch, Uwe Zeymer, the ARIADNE investigators
Publikováno v:
ESC Heart Failure, Vol 9, Iss 6, Pp 4209-4218 (2022)
Abstract Aims ARIADNE aimed to assess the association between effects of sacubitril/valsartan and no sacubitril/valsartan treatment and clinical characteristics, functional capacity, and clinical outcomes (cause‐specific mortality and hospitalizati
Externí odkaz:
https://doaj.org/article/1e95d61631394164bb9aeae759fd023a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
the ARIADNE investigators
Funding Information: APM reports personal fees from Novartis during the conduct of the study and personal fees from Bayer, personal fees from AstraZeneca, and personal fees from Fresenius, outside the submitted work. ALC reports personal fees and non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1437::bfab9bb02fe26e18f7df95d24c720a05
https://hdl.handle.net/10362/144429
https://hdl.handle.net/10362/144429
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ariadne investigators, Andrew L. Clark, Cornelia Koch, Aldo P. Maggioni, Thibaud Damy, Vivencio Barrios, Lars Lund, Candisda Fonseca, Stefanie Kalus, Jarosław Drożdż, Uwe Zeymer, Rizwan I Hussain, Philippe Ferber
Publikováno v:
European heart journal. Quality of careclinical outcomes. 8(4)
Aims To compare baseline characteristics of patients with heart failure with reduced ejection fraction (HFrEF) initiated on sacubitril/valsartan compared with patients continued on conventional heart failure (HF)-treatment in a European out-patient s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f29712f80e561a117f5ec623f9e149df
https://pubmed.ncbi.nlm.nih.gov/33725113
https://pubmed.ncbi.nlm.nih.gov/33725113
Autor:
A.P. Maggioni, Lars Lund, S Kalus, Jarosław Drożdż, Andrew L. Clark, Cornelia Koch, Thibaud Damy, Candida Fonseca, Barrios, Ariadne investigators, Uwe Zeymer
Publikováno v:
European Heart Journal. 41
Background Recently, the angiotensin receptor neprilysin inhibitor (ARNI) sacubitril/valsartan (S/V) was introduced as a novel therapeutic option into European guidelines for the management of heart failure (HF). The Assessment of Real lIfe cAre –D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04fb1a9b890d67f68deb1de649ca4abf
https://doi.org/10.1093/ehjci/ehaa946.1031
https://doi.org/10.1093/ehjci/ehaa946.1031
Autor:
Ariadne investigators, A.P. Maggioni, Jarosław Drożdż, Thibaud Damy, Lars Lund, Cornelia Koch, Candida Fonseca, Uwe Zeymer, Andrew L. Clark, S Kalus, Barrios
Publikováno v:
European Heart Journal. 41
Background Heart failure (HF) is a major medical and economic burden that is often managed in office based practices. Recently, the angiotensin receptor neprilysin inhibitor (ARNI) sacubitril/valsartan (S/V) was introduced as novel therapeutic option
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd377aa887d70e2094f62c244db95235
https://doi.org/10.1093/ehjci/ehaa946.1063
https://doi.org/10.1093/ehjci/ehaa946.1063
Autor:
Andrew L. Clark, Lars Lund, Ariadne investigators, Uwe Zeymer, Candida Fonseca, Jarosław Drożdż, S Kalus, Cornelia Koch, Barrios, A.P. Maggioni, Thibaud Damy
Publikováno v:
European Heart Journal. 41
Background Recently, the angiotensin receptor neprilysin inhibitor (ARNI) sacubitril/valsartan was introduced as novel therapeutic option into European guidelines for the management of heart failure. The ARIADNE registry provides information about it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d72e29683329f036b82db5873db34ece
https://doi.org/10.1093/ehjci/ehaa946.1062
https://doi.org/10.1093/ehjci/ehaa946.1062
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Andrew L. Clark, Uwe Zeymer, Ariadne investigators, Stephan Hupfer, Candida Fonseca, Thibaud Damy, Vivencio Barrios, A.P. Maggioni, Jarosław Drożdż, Lars Lund
Publikováno v:
European Heart Journal. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::483641607f763f91c3b6b835c391ba68
https://doi.org/10.1093/eurheartj/ehy564.p908
https://doi.org/10.1093/eurheartj/ehy564.p908